Follo MY - Search Results

1

Advances in MDS/AML and inositide signalling.

De Stefano A, Marvi MV, Fazio A, McCubrey JA, Suh PG, Ratti S, Ramazzotti G, Manzoli L, Cocco L, Follo MY. De Stefano A, et al. Among authors: follo my. Adv Biol Regul. 2023 Jan;87:100955. doi: 10.1016/j.jbior.2023.100955. Epub 2023 Jan 21. Adv Biol Regul. 2023. PMID: 36706610 Free article.

2

Nuclear inositol lipid metabolism: more than just second messenger generation?

Martelli AM, Follo MY, Evangelisti C, Falà F, Fiume R, Billi AM, Cocco L. Martelli AM, et al. Among authors: follo my. J Cell Biochem. 2005 Oct 1;96(2):285-92. doi: 10.1002/jcb.20527. J Cell Biochem. 2005. PMID: 16088939 Review.

3

Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction.

Martelli AM, Fiume R, Faenza I, Tabellini G, Evangelista C, Bortul R, Follo MY, Falà F, Cocco L. Martelli AM, et al. Among authors: follo my. Histol Histopathol. 2005 Oct;20(4):1251-60. doi: 10.14670/HH-20.1251. Histol Histopathol. 2005. PMID: 16136505 Review.

4

Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation.

Faenza I, Billi AM, Follo MY, Fiume R, Martelli AM, Cocco L, Manzoli L. Faenza I, et al. Among authors: follo my. Anticancer Res. 2005 May-Jun;25(3B):2039-41. Anticancer Res. 2005. PMID: 16158942 Free article. Review.

5

Real-time PCR as a tool for quantitative analysis of PI-PLCbeta1 gene expression in myelodysplastic syndrome.

Follo MY, Bosi C, Finelli C, Fiume R, Faenza I, Ramazzotti G, Gaboardi GC, Manzoli L, Cocco L. Follo MY, et al. Int J Mol Med. 2006 Aug;18(2):267-71. Int J Mol Med. 2006. PMID: 16820933

6

Inositide-dependent phospholipase C signaling mimics insulin in skeletal muscle differentiation by affecting specific regions of the cyclin D3 promoter.

Faenza I, Ramazzotti G, Bavelloni A, Fiume R, Gaboardi GC, Follo MY, Gilmour RS, Martelli AM, Ravid K, Cocco L. Faenza I, et al. Among authors: follo my. Endocrinology. 2007 Mar;148(3):1108-17. doi: 10.1210/en.2006-1003. Epub 2006 Nov 22. Endocrinology. 2007. PMID: 17122077

7

Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cells.

Cocco L, Follo MY, Faenza I, Bavelloni A, Billi AM, Martelli AM, Manzoli L. Cocco L, et al. Among authors: follo my. Adv Enzyme Regul. 2007;47:2-9. doi: 10.1016/j.advenzreg.2006.12.003. Epub 2007 Mar 1. Adv Enzyme Regul. 2007. PMID: 17335878 Review. No abstract available.

8

The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation.

Follo MY, Mongiorgi S, Bosi C, Cappellini A, Finelli C, Chiarini F, Papa V, Libra M, Martinelli G, Cocco L, Martelli AM. Follo MY, et al. Cancer Res. 2007 May 1;67(9):4287-94. doi: 10.1158/0008-5472.CAN-06-4409. Cancer Res. 2007. PMID: 17483341

9

Nuclear phospholipase C beta1 and cellular differentiation.

Faenza I, Bregoli L, Ramazzotti G, Gaboardi G, Follo MY, Mongiorgi S, Billi AM, Manzoli L, Martelli AM, Cocco L. Faenza I, et al. Among authors: follo my. Front Biosci. 2008 Jan 1;13:2452-63. doi: 10.2741/2858. Front Biosci. 2008. PMID: 17981726 Review.

10

Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes.

Cocco L, Faenza I, Follo MY, Ramazzotti G, Gaboardi GC, Billi AM, Martelli AM, Manzoli L. Cocco L, et al. Among authors: follo my. Adv Enzyme Regul. 2008;48:2-9. doi: 10.1016/j.advenzreg.2007.11.013. Epub 2008 Mar 17. Adv Enzyme Regul. 2008. PMID: 18280812 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page